Evident, Occult and no Demonstrated USI and UDS Findings in Women With ≥Stage II Cystocele

Sponsor
National Taiwan University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03613311
Collaborator
(none)
480
78.9

Study Details

Study Description

Brief Summary

Prevalence rates of urodynamic urinary incontinence (USI) subtypes and their related clinical and urodynamic findings in women with ≥ pelvic organ prolapse quantification stage II cystocele are important for clinical consultation, especially for occult USI. Misdiagnosis of occult USI before cystocele repair might lead to occurrence of de novo stress urinary incontinence after cystocele repair. Thus, the aim of this study was to elucidate the above findings and between-group associations.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Urodynamic study

Detailed Description

Between November 2011 and January 2017, medical records of all women with ≥stage II cystocele who underwent urodynamic studies in a medical center were reviewed. ANOVA test and post-hoc testing with bonferroni's correction were used for statistical analysis. USI is noted during filling cystometry and is defined as the involuntary leakage of urine during increased abdominal pressure, in the absence of a detrusor contraction. The recruited patients with cystocele were classified into three groups (i.e.,evident USI, occult USI and no demonstrated USI) according to pad weight results before and after prolapse reduction.

Study Design

Study Type:
Observational
Actual Enrollment :
480 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Prevalence Rates of Evident, Occult and no Demonstrated Urodynamic Stress Incontinence and Their Clinical and Urodynamic Findings in Women With ≥Stage II Cystocele
Actual Study Start Date :
Nov 1, 2011
Actual Primary Completion Date :
Jan 31, 2017
Actual Study Completion Date :
May 31, 2018

Arms and Interventions

Arm Intervention/Treatment
Evident urodynamic stress incontinence(USI)

Between November 2011 and January 2017, medical records of all women with ≥stage II cystocele who underwent urodynamic studies in a medical center were reviewed. USI is noted during filling cystometry and is defined as the involuntary leakage of urine during increased abdominal pressure, in the absence of a detrusor contraction.

Diagnostic Test: Urodynamic study
Urodynamic study: including uroflowmetry, filling cystometry, voiding cystometry, and urethral pressure profile

Occult USI

Between November 2011 and January 2017, medical records of all women with ≥stage II cystocele who underwent urodynamic studies in a medical center were reviewed. USI is noted during filling cystometry and is defined as the involuntary leakage of urine during increased abdominal pressure, in the absence of a detrusor contraction after prolapse reduction by vaginal gauze.

Diagnostic Test: Urodynamic study
Urodynamic study: including uroflowmetry, filling cystometry, voiding cystometry, and urethral pressure profile

ND USI

Between November 2011 and January 2017, medical records of all women with ≥stage II cystocele who underwent urodynamic studies in a medical center were reviewed. No USI was noted in this group.

Diagnostic Test: Urodynamic study
Urodynamic study: including uroflowmetry, filling cystometry, voiding cystometry, and urethral pressure profile

Outcome Measures

Primary Outcome Measures

  1. Evident USI [Between November 2011 and January 2017]

    USI note before reduction of prolapse

  2. Occult USI [Between November 2011 and January 2017]

    USI note after reduction of prolapse

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age >20y/o

  2. Cystocele > stage II

  3. Complete urodynamic study

Exclusion Criteria:
  1. Pregnancy

  2. Urinary tract infection

  3. Previous pelvic reconstruction surgery

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • National Taiwan University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT03613311
Other Study ID Numbers:
  • 201805048RIN
First Posted:
Aug 3, 2018
Last Update Posted:
Aug 3, 2018
Last Verified:
Jul 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by National Taiwan University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 3, 2018